The 40-Gene Expression Profile Test Identifies Patients With National Comprehensive Cancer Network High-Risk Cutaneous Squamous Cell Carcinoma at High Risk of Poor Outcomes to Inform Management Decisions. J of Skin 2025, 9 (4), 2426-2443. https://doi.org/10.25251/mvr2rn83.